APA (7th ed.) Citation

Richardet, E., Acosta, L. P., Magi, I., tello Alfonso, R., Peruchin, R. V., Perea, P., . . . Richardet, M. (2022). Update to role of the neutrophil lymphocyte ratio in patients with advanced NSCLC undergoing immunotherapy. Journal of clinical oncology, 40(16_suppl), e21041. https://doi.org/10.1200/JCO.2022.40.16_suppl.e21041

Chicago Style (17th ed.) Citation

Richardet, Eduardo, Luciana Paola Acosta, Ignacio Magi, Rocio tello Alfonso, Rita Vanessa Peruchin, Pablo Perea, Matias Molina, and Martin Richardet. "Update to Role of the Neutrophil Lymphocyte Ratio in Patients with Advanced NSCLC Undergoing Immunotherapy." Journal of Clinical Oncology 40, no. 16_suppl (2022): e21041. https://doi.org/10.1200/JCO.2022.40.16_suppl.e21041.

MLA (9th ed.) Citation

Richardet, Eduardo, et al. "Update to Role of the Neutrophil Lymphocyte Ratio in Patients with Advanced NSCLC Undergoing Immunotherapy." Journal of Clinical Oncology, vol. 40, no. 16_suppl, 2022, p. e21041, https://doi.org/10.1200/JCO.2022.40.16_suppl.e21041.